Pfizer tops in U.K. research linkups; India's Torrent wraps up Zyg buy;

@FiercePharma: We've got a brand new special report today! Top 10 pharma companies in social media. Feature | Follow @FiercePharma

@EricPFierce: ICYMI: Gallant Pharma owner notified in jail by FDA he is disbarred for life from the pharma industry. More from PharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: Baxalta tots up winning hemophilia data as new med beats Advate in late-stage trial. More from FiercePharmaMarketing | Follow @CarlyHFierce

> Pfizer ($PFE), which stirred up a big political controversy in the U.K. when it tried to buy AstraZeneca ($AZN) last year, was ranked the top foreign research partner in the country in a new government report. Article

> India's Torrent Pharmaceuticals wrapped up its buyout of the dermatology drug specialist Zyg Pharma. Report

> GlaxoSmithKline ($GSK) said it's hard at work combating counterfeit drugs in Nigeria, where the company has a consumer healthcare partnership with pharmacists. Report

> Demand for over-the counter drugs in the U.K. jumped by 6.7% in the 12 months ended in February, a change experts linked partly to the National Health Service's emphasis on patient self-care. Report

Medical Device News

@FierceMedDev: Illumina launches new lab service for HiSeq X sequencing systems. FierceDiagnostics article | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Study finds Philips' ventilator helps reduce hospital readmissions for COPD. Article | Follow @VarunSaxena2

@EmilyWFierce: In 10 years, liquid biopsy test for cancer will be part of routine annual exams, says Guardant Health CEO. More from the WSJ | Follow @EmilyWFierce

> Hospitals launch trial to test AliveCor's iPhone-enabled ECG for diagnosis of heart attacks. Report

> Early study results indicate EndoStim's implant is effective for treating acid reflux. Story

> Stryker to buy Turkish partner in its second hospital bed acquisition in 2015. More

> NIH-backed scientists develop wireless, remote-controlled brain implant. Article

Biotech News

@FierceBiotech: Bristol-Myers flags an early success for PhIII Opdivo study. Article | Follow @FierceBiotech

@JohnCFierce: Americans want Medicare to negotiate lower drug prices -- (one day it's going to come). More from Reuters | Follow @JohnCFierce

> Tekmira changes its name and shuffles away from Ebola. News

> Agenus bags cancer antibodies in $44M deal. More

> Another Alzheimer's upstart swings for a $150M IPO with a PhIII contender. Article

> Bristol-Myers flags early success for PhIII Opdivo study in kidney cancer. Report

Animal Health News

> KC Animal Health Corridor investment forum slated for early September. More

> Aratana charts positive results for canine pain drug, predicts 2016 launch. Report

> PetCure spots booming market for radiosurgery in pets with cancer. Story

> Valeant steps into animal health with $800M acquisition of Egypt's Amoun. Article

> Virbac charts strong sales growth, nabs Big Pharma veteran to oversee quality. Item

Biotech IT News

> FDA turns to Google for help spotting adverse events. Report

> Vermillion raises $18.8M to fund escalation of bioinformatics ambitions. News

> Illumina wraps lab automation and software around HiSeq X to lower barrier to mass sequencing. Article

> Report: Danaher nears $30M buyout of computer-aided imaging business. More

> Arivale sets up with $36M, A-list founders and one eye on the R&D potential of its 'dense data clouds.' Story

Pharma Marketing News

> Does high TV ad rotation give patients the wrong idea about drugs? More

> Opdivo trial stopped early as BMS med tops Afinitor in kidney cancer. Item

> AstraZeneca ponies up for heart-attack patients with new Vida Health app. Report

> VC to pharma: Better get on board with digital health marketing. Story

> Lilly adds new Coco the Type 1 monkey tale to its Disney bookshelf. Article

And Finally... Did an early push to add HPV shots to the mandatory vaccinations list end up backfiring on the products? Report

Suggested Articles

Johnson & Johnson has teamed up with Michigan's Grand River Aseptic Manufacturing (GRAM) to handle fill-finish duties for its COVID-19 shot hopeful.

Belén Garijo, currently CEO of Merck Healthcare, will succeed Stefan Oschmann as the German company's chief exec when his tenure ends in April 2021.

More than 60 researchers and bioethicists called on Pfizer to take time to collect more COVID-19 vaccine safety data, Bloomberg reports.